NCT01713296 - Pazopanib in Relapsed and Refractory Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

SCLC

Interventions

DRUG

Pazopanib

Trial Locations (8)

"Agioi Anargyroi Anticancer Hospital of Athens", Athens

"IASO General Hospital of Athens", Athens

401 Military Hospital of Athens, Athens

Air Forces Military Hospital of Athens, Athens

University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece, Heraklion

"Metaxa's Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology", Piraeus

"Papageorgiou Hospital of Thessaloniki", Thessaloniki

"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki